Liver Transplantation: Clinical Trials

43 trials for Liver Transplantation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed, 13 unknown, 3 terminated, 2 recruiting. 43 Phase 2, 7 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 243Completed 23, Unknown 13, Terminated 3, Recruiting 2, Active not recruiting 1, Enrolling by invitation 1
Phase 17Completed 3, Unknown 2, Enrolling by invitation 1, Recruiting 1
Phase 34Unknown 3, Completed 1

Follow Liver Transplantation: new trials by email Literature Review of Liver Transplantation trials Research Report on Liver Transplantation

Trials (filtered) newest first · largest first

All 43 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immune Tolerance Induction After Liver Transplantation
Donor Hematopoietic Stem and Progenitor Cell Infusion - Liver Transplantation, Immune Tolerance
Phase 1 / Phase 2RecruitingUniversity of California, Los Angeles122026-02-202026-03-12
Secretin in Ex-situ Liver Perfusion
Secretin administration during ex-situ liver machine perfusion - Liver Transplantation
Phase 1 / Phase 2Enrolling by invitationErasmus Medical Center202025-04-262026-06-16
Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation
Downstaging procedures containing immunotherapy, Liver transplantation - Liver Transplantation, Hepatocellular Carcinoma
Phase 2RecruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University592023-06-212024-11-29
A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation
TCD601, Cyclophosphamide, TAC - Liver Transplantation
Phase 2Active not recruitingITB-Med LLC122022-06-292024-11-27
A Feasibility Study of Octreotide Infusion During Liver Transplant.
Octreotide Acetate, Placebo - Liver Transplantation, Renal Failure
Phase 2UnknownUniversity College, London302022-05-272023-05-03
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in ABO-Incompatible Liver Transplantation
LIV-GAMMA SN Inj., No intervention - Liver Transplantation
Phase 2TerminatedSK Plasma Co., Ltd.592022-04-252024-08-30
Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation
[18F]FSPG - Graft Rejection, Heart Transplantation
Phase 2CompletedAsan Medical Center72020-11-182023-07-20
Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantation
Ascorbic acid, 0.9% Saline solution - Liver Transplantation, Postreperfusion Syndrome
Phase 2UnknownHospital Universitario Ramon y Cajal702020-11-172023-03-03
Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
lenvatinib, Placebo - Hepatocellular Carcinoma, Portal Vein Tumor Thrombus
Phase 2 / Phase 3UnknownRenJi Hospital1082020-05-022020-03-24
Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation
Immuncell-LC - Liver Transplantation
Phase 1 / Phase 2CompletedGC Cell Corporation192019-01-242023-06-22
Study to Assess the Effect of Intravenous Supplementation of Omega-3 Fatty Acids on Outcome of Recipients in Living Donor Liver Transplantation
Omega 3 fatty acid - Liver Transplantation
Phase 2UnknownInstitute of Liver and Biliary Sciences, India1242018-12-022019-07-23
Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantation
Tacrolimus, Tacrolimus (Tacrolimus elimination), Sirolimus - Liver Transplantation
Phase 2 / Phase 3UnknownSouthern Medical University, China1302018-05-012018-04-18
Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation
Terlipressin, Normal saline - Terlipressin Adverse Reaction, Liver Transplantation
Phase 2CompletedKasr El Aini Hospital302018-01-252018-12-24
Post Static Cold Storage Normothermic Machine Liver Perfusion
Normothermic Machine Liver Perfusion - Liver Transplantation
Phase 1 / Phase 2UnknownUniversity of Oxford302017-05-012017-06-05
Efficacy of Low Dose, SubQ Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipients
Interleukin-2 - Liver Transplantation
Phase 2CompletedBeth Israel Deaconess Medical Center62016-11-012026-01-13
Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation
Immunosuppression withdrawal - Liver Transplant, Liver Transplantation
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1002015-12-152023-09-14
Therapeutic Strategy and the Role of Mesenchymal Stromal Cells for ABO Incompatible Liver Transplantation
Mesenchymal Stem Cells(MSCs) - Liver Transplantation
Phase 1 / Phase 2UnknownThird Affiliated Hospital, Sun Yat-Sen University152014-02-012016-03-11
Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.
Extracorporeal Photopheresis Procedure (FEC) - Liver Transplantation, Immunosuppression
Phase 1 / Phase 2CompletedRed de Terapia Celular102013-04-012017-03-30
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
Immunosuppression withdrawal - Liver Transplant Recipients, Liver Transplantation
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1612012-08-142019-10-07
A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
Tacrolimus, Tacrolimus prolonged release - Heart Transplantation, Kidney Transplantation
Phase 2CompletedAstellas Pharma Europe Ltd.442012-04-032024-11-01

Showing 20 of 43. Sign in to see all of them.

Narrower conditions

Carcinoma, Hepatocellular (4)  ·  Hepatitis C (3)  ·  Renal Insufficiency (3)  ·  Hepatitis B (2)  ·  Bone Resorption (1)  ·  Cholestasis (1)  ·  End Stage Liver Disease (1)  ·  Hepatitis (1)  ·  Invasive Fungal Infections (1)  ·  Liver Diseases (1)  ·  Mycoses (1)  ·  Rejection, Psychology (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Digestive System Diseases (11)  ·  Liver Diseases (10)  ·  Infections (6)  ·  Blood-Borne Infections (5)  ·  Communicable Diseases (5)  ·  Hepatitis (5)  ·  Hepatitis, Viral, Human (5)  ·  Virus Diseases (5)  ·  Adenocarcinoma (4)  ·  Carcinoma (4)  ·  Digestive System Neoplasms (4)  ·  Liver Neoplasms (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms by Site (4)

Interventions

Tacrolimus (11)  ·  Mycophenolic Acid (5)  ·  Saline Solution (3)  ·  Liver Transplantation (2)  ·  Prednisone (2)  ·  Sirolimus (2)  ·  Steroids (2)  ·  2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-hepten-6-ynamide (1)  ·  3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid (1)  ·  4-(3-fluoropropyl)glutamic acid (1)  ·  Adrenal Cortex Hormones (1)  ·  Alemtuzumab (1)  ·  Alendronate (1)  ·  Ascorbic Acid (1)  ·  BID protein, human (1)

Sponsors

Astellas Pharma Inc (5)  ·  Hospital Clinic of Barcelona (3)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  Astellas Pharma Europe Ltd. (2)  ·  Columbia University (2)  ·  Armin Goralczyk (1)  ·  Asan Medical Center (1)  ·  Beijing Chao Yang Hospital (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Conatus Pharmaceuticals Inc. (1)  ·  Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1)  ·  Erasmus Medical Center (1)  ·  GC Cell Corporation (1)  ·  Grupo de Estudio de Infecciones en Transplantados (1)  ·  Hospital Universitario Ramon y Cajal (1)

Countries

United States (13)  ·  Spain (10)  ·  Germany (8)  ·  France (7)  ·  United Kingdom (7)  ·  Italy (6)  ·  Canada (5)  ·  Czechia (5)  ·  China (4)  ·  South Korea (4)  ·  Belgium (3)  ·  Poland (3)  ·  Austria (2)  ·  Netherlands (2)  ·  Sweden (2)

Top investigators

Alberto Sanchez-Fueyo, MD (2)  ·  Giuseppe Tisone, MD (2)  ·  Aiman Obed, PD Dr. (1)  ·  Alberto Sanchez Fueyo, MD (1)  ·  Andreas A Schnitzbauer, MD (1)  ·  Armin D Goralczyk, Dr. (1)  ·  Cray V. Noah, MD (1)  ·  Dae Hyuk Moon, MD (1)  ·  Deborah C. Molrine, MD (1)  ·  Ding Ma, M.D. (1)  ·  Elizabeth Shane, M.D. (1)

Results publications

PMID 20380712, PMID 23024190, PMID 23356386, PMID 25677074, PMID 26729653, PMID 30178515, PMID 32786149, PMID 33280227, PMID 35819312, PMID 38100226, PMID 40719561, PMID 41128798, PMID 41500624

NIH funding

U01AI100807 (1)